• Skip to main content
  • Skip to navigation
Accessibility
  • Increase font size
  • Decrease font size
  • Sharpen color
  • Grayscale
  • Invert color
  • Default
Disclaimerclose
Home

YEDA Technology Transfer from the Weizmann Institute of Science

Yeda Research and Development

Contact Us
Briefcase
Become a member
Menu
  • Home
  • About Us
    • About Us
    • Board of Directors
    • For Entrepreneurs
    • Our Team
    • Close
  • Technologies
    • AgroTech & FoodTech
    • BioPlatforms
    • ClimateTech
    • DeepTech
    • Diagnostics
    • Material Science
    • MedTech & Digital Health
    • Research Tools
    • Software & Algorithms
    • Therapeutics
    • Close
  • Success Stories
  • Our spinoffs
  • News & Events
    • News & Events
    • Newsletters
    • Close
  • For researchers
  • Become a Member
  • Close
  • Technologies(157)
  • Research Experts(103)
  • Success Stories(2)
  • Our Spinoffs(55)
  • News & Events(175)

You are here

  1. Home ›
  2. Search ›
  3. Technologies

Results for technologies (4)

Advanced filter
Research Tools

Pmel-1 TCR transduced cells (No. M7-2265)

This T-cell line, derived from the BWZ.36/CD8a thymoma of murine origin, was genetically engineered to express CD3 and a codon-optimized Pmel-1 T-cell receptor (TCR) through sequential retroviral transductions. Bassan et al., Int J Cancer, 2019. ... Read more
Emeritus Rachel Lea Eisenbach

Rachel Lea Eisenbach

Faculty of Biology

Share buttons
Share on facebook
Share on twitter
Share on Google +
Share with Email
19345
Research Tools

B16F10.9 Cell Line (No. M7-2179)

Spontaneous metastatic spread of melanoma after surgery of the primary tumor. immunization against melanoma metastasis Relevance: A model to study melanoma metastasis in mice. Melanoma metastatic spread, immunization against melanoma metastasis Relevant disease: melanoma Porgador ... Read more
Emeritus Rachel Lea Eisenbach

Rachel Lea Eisenbach

Faculty of Biology

Share buttons
Share on facebook
Share on twitter
Share on Google +
Share with Email
19329
Therapeutics

Optimized MAGE-A1 targeting TCR for T-cell Therapy (No. T4-1662)

TCR gene therapies show promise in cancer treatment but are hindered by the low natural avidity of TCRs against tumor-associated antigens. MAGE-A1 is a germline antigen expressed in many tumor types, making it a compelling target for TCR-based immunotherapy. Cell therapy for MAGE-... Read more
Emeritus Rachel Lea Eisenbach

Rachel Lea Eisenbach

Faculty of Biology

Share buttons
Share on facebook
Share on twitter
Share on Google +
Share with Email
5572
Research Tools

Anti - gp100 T - cell Secreting Hybridoma [BUSA14 cell line] (No. M7-397)

Hybridoma cell line [clone BUSA14] which generates lacZ inducible CD8+ T -cells capable of recognizing both human and mouse gp100(25-33) melanoma antigens presented on dendritic and tumor cell lines. Cafri G, Sharbi-Yunger A, Tzehoval E, Eisenbach L. Production of LacZ Inducible T... Read more

Adi Sharbi-Yunger

Biology

Emeritus Rachel Lea Eisenbach

Rachel Lea Eisenbach

Faculty of Biology

Gal Cafri

Dr Esther Tzehoval

Esther Tzehoval

Faculty of Biology

Share buttons
Share on facebook
Share on twitter
Share on Google +
Share with Email
19317

User login

  • Request new password
  • Home
  • About Us
    • About Us
    • Board of Directors
    • For Entrepreneurs
    • Our Team
    • Close
  • Technologies
    • AgroTech & FoodTech
    • BioPlatforms
    • ClimateTech
    • DeepTech
    • Diagnostics
    • Material Science
    • MedTech & Digital Health
    • Research Tools
    • Software & Algorithms
    • Therapeutics
    • Close
  • Success Stories
  • Our spinoffs
  • News & Events
    • News & Events
    • Newsletters
    • Close
  • For researchers
  • Become a Member
  • Close

footer

Yeda Research & Development Co. Ltd, P.O Box 95, Rehovot 7610002, Israel
Tel. +972.8.9470617 | Fax. +972.8.9470739
Privacy-Policy youtube twitter facebook linkedin instagram